Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 576 entries
Sorted by: Best Match Show Resources per page
Insulin-Induced Distant Site Lipoatrophy.

Diabetes care

Kondo A, Nakamura A, Takeuchi J, Miyoshi H, Atsumi T.
PMID: 28396362
Diabetes Care. 2017 Jun;40(6):e67-e68. doi: 10.2337/dc16-2385. Epub 2017 Apr 10.

No abstract available.

Cite
Kondo A, Nakamura A, Takeuchi J, et al. Insulin-Induced Distant Site Lipoatrophy. Diabetes Care. 2017;40(6):e67-e68doi: 10.2337/dc16-2385.
Kondo, A., Nakamura, A., Takeuchi, J., Miyoshi, H., & Atsumi, T. (2017). Insulin-Induced Distant Site Lipoatrophy. Diabetes care, 40(6), e67-e68. https://doi.org/10.2337/dc16-2385
Kondo, Aki, et al. "Insulin-Induced Distant Site Lipoatrophy." Diabetes care vol. 40,6 (2017): e67-e68. doi: https://doi.org/10.2337/dc16-2385
Kondo A, Nakamura A, Takeuchi J, Miyoshi H, Atsumi T. Insulin-Induced Distant Site Lipoatrophy. Diabetes Care. 2017 Jun;40(6):e67-e68. doi: 10.2337/dc16-2385. Epub 2017 Apr 10. PMID: 28396362.
Copy Download .nbib Format: NLM
Screening for hemostatic activities of popular Chinese medicinal herbs in vitro.

Journal of intercultural ethnopharmacology

Ohkura N, Yokouchi H, Mimura M, Nakamura R, Atsumi G.
PMID: 26401379
J Intercult Ethnopharmacol. 2015 Jan-Mar;4(1):19-23. doi: 10.5455/jice.20141128032845. Epub 2015 Jan 03.

AIMS: This study aimed to identify new hemostyptics by assessing the coagulation enhancing activity of 114 Chinese herbal extracts in vitro.METHODS: Herbs were boiled in water for 30 min, filtered and then lyophilized filtrates (10 mg/mL) were dissolved in...

Cite
Ohkura N, Yokouchi H, Mimura M, et al. Screening for hemostatic activities of popular Chinese medicinal herbs in vitro. J Intercult Ethnopharmacol. 2015;4(1):19-23doi: 10.5455/jice.20141128032845.
Ohkura, N., Yokouchi, H., Mimura, M., Nakamura, R., & Atsumi, G. (2015). Screening for hemostatic activities of popular Chinese medicinal herbs in vitro. Journal of intercultural ethnopharmacology, 4(1), 19-23. https://doi.org/10.5455/jice.20141128032845
Ohkura, Naoki, et al. "Screening for hemostatic activities of popular Chinese medicinal herbs in vitro." Journal of intercultural ethnopharmacology vol. 4,1 (2015): 19-23. doi: https://doi.org/10.5455/jice.20141128032845
Ohkura N, Yokouchi H, Mimura M, Nakamura R, Atsumi G. Screening for hemostatic activities of popular Chinese medicinal herbs in vitro. J Intercult Ethnopharmacol. 2015 Jan-Mar;4(1):19-23. doi: 10.5455/jice.20141128032845. Epub 2015 Jan 03. PMID: 26401379; PMCID: PMC4566763.
Copy Download .nbib Format: NLM
Inhibition of Glucan Synthesis by Flavipin-crosslinked Casein Polymers.

Bioscience, biotechnology, and biochemistry

Hayashida O, Nakano Y, Hasumi K, Endo A.
PMID: 28862563
Biosci Biotechnol Biochem. 1997 Jan;61(5):903-904. doi: 10.1271/bbb.61.903.

Mutastein, a casein polymer that inhibits insoluble glucan synthesis by Streptococcus sobrinus, was produced when Aspergillus terreus was grown in a medium containing α-casein. In these experiments, it was shown that flavipin (3,4,5-trihydroxy-6-methyl-o-phthalaldehyde) isolated from cultures of A. terreus...

Cite
Hayashida O, Nakano Y, Hasumi K, et al. Inhibition of Glucan Synthesis by Flavipin-crosslinked Casein Polymers. Biosci Biotechnol Biochem. 1997;61(5):903-904doi: 10.1271/bbb.61.903.
Hayashida, O., Nakano, Y., Hasumi, K., & Endo, A. (1997). Inhibition of Glucan Synthesis by Flavipin-crosslinked Casein Polymers. Bioscience, biotechnology, and biochemistry, 61(5), 903-904. https://doi.org/10.1271/bbb.61.903
Hayashida, Osamu, et al. "Inhibition of Glucan Synthesis by Flavipin-crosslinked Casein Polymers." Bioscience, biotechnology, and biochemistry vol. 61,5 (1997): 903-904. doi: https://doi.org/10.1271/bbb.61.903
Hayashida O, Nakano Y, Hasumi K, Endo A. Inhibition of Glucan Synthesis by Flavipin-crosslinked Casein Polymers. Biosci Biotechnol Biochem. 1997 Jan;61(5):903-904. doi: 10.1271/bbb.61.903. PMID: 28862563.
Copy Download .nbib Format: NLM
Redox active dendronized polystyrenes equipped with peripheral triarylamines.

Beilstein journal of organic chemistry

Nokami T, Musya N, Morofuji T, Takeda K, Takumi M, Shimizu A, Yoshida J.
PMID: 25670978
Beilstein J Org Chem. 2014 Dec 22;10:3097-103. doi: 10.3762/bjoc.10.326. eCollection 2014.

Dendronized polystyrene having peripheral bromo groups was prepared from the dendronization of unfunctionalized polystyrene with dendritic diarylcarbenium ions bearing peripheral bromo groups using the "cation pool" method. The palladium-catalyzed amination of the peripheral bromo groups with diarylamine gave dendronized...

Cite
Nokami T, Musya N, Morofuji T, et al. Redox active dendronized polystyrenes equipped with peripheral triarylamines. Beilstein J Org Chem. 2014;10:3097-103doi: 10.3762/bjoc.10.326.
Nokami, T., Musya, N., Morofuji, T., Takeda, K., Takumi, M., Shimizu, A., & Yoshida, J. (2014). Redox active dendronized polystyrenes equipped with peripheral triarylamines. Beilstein journal of organic chemistry, 103097-103. https://doi.org/10.3762/bjoc.10.326
Nokami, Toshiki, et al. "Redox active dendronized polystyrenes equipped with peripheral triarylamines." Beilstein journal of organic chemistry vol. 10 (2014): 3097-103. doi: https://doi.org/10.3762/bjoc.10.326
Nokami T, Musya N, Morofuji T, Takeda K, Takumi M, Shimizu A, Yoshida J. Redox active dendronized polystyrenes equipped with peripheral triarylamines. Beilstein J Org Chem. 2014 Dec 22;10:3097-103. doi: 10.3762/bjoc.10.326. eCollection 2014. PMID: 25670978; PMCID: PMC4311719.
Copy Download .nbib Format: NLM
Development of cancer-initiating cells and immortalized cells with genomic instability.

World journal of stem cells

Yoshioka K, Atsumi Y, Nakagama H, Teraoka H.
PMID: 25815132
World J Stem Cells. 2015 Mar 26;7(2):483-9. doi: 10.4252/wjsc.v7.i2.483.

Cancers that develop after middle age usually exhibit genomic instability and multiple mutations. This is in direct contrast to pediatric tumors that usually develop as a result of specific chromosomal translocations and epigenetic aberrations. The development of genomic instability...

Cite
Yoshioka K, Atsumi Y, Nakagama H, et al. Development of cancer-initiating cells and immortalized cells with genomic instability. World J Stem Cells. 2015;7(2):483-9doi: 10.4252/wjsc.v7.i2.483.
Yoshioka, K., Atsumi, Y., Nakagama, H., & Teraoka, H. (2015). Development of cancer-initiating cells and immortalized cells with genomic instability. World journal of stem cells, 7(2), 483-9. https://doi.org/10.4252/wjsc.v7.i2.483
Yoshioka, Ken-Ichi, et al. "Development of cancer-initiating cells and immortalized cells with genomic instability." World journal of stem cells vol. 7,2 (2015): 483-9. doi: https://doi.org/10.4252/wjsc.v7.i2.483
Yoshioka K, Atsumi Y, Nakagama H, Teraoka H. Development of cancer-initiating cells and immortalized cells with genomic instability. World J Stem Cells. 2015 Mar 26;7(2):483-9. doi: 10.4252/wjsc.v7.i2.483. PMID: 25815132; PMCID: PMC4369504.
Copy Download .nbib Format: NLM
Examination of the clinical efficacy of eribulin and trastuzumab in HER2-positive recurrent breast cancer.

Molecular and clinical oncology

Kiba T, Morii N, Takahashi H, Ozaki S, Atsumi M, Masumoto F, Shitakubo Y, Yamashiro H.
PMID: 26870356
Mol Clin Oncol. 2016 Jan;4(1):47-50. doi: 10.3892/mco.2015.668. Epub 2015 Nov 05.

There are limited studies reported that describe the efficacy of eribulin and trastuzumab in the treatment of recurrent breast cancer. The present study examined the therapeutic efficacy of eribulin and trastuzumab in the treatment of recurrent breast cancer. Between...

Cite
Kiba T, Morii N, Takahashi H, et al. Examination of the clinical efficacy of eribulin and trastuzumab in HER2-positive recurrent breast cancer. Mol Clin Oncol. 2015;4(1):47-50doi: 10.3892/mco.2015.668.
Kiba, T., Morii, N., Takahashi, H., Ozaki, S., Atsumi, M., Masumoto, F., Shitakubo, Y., & Yamashiro, H. (2016). Examination of the clinical efficacy of eribulin and trastuzumab in HER2-positive recurrent breast cancer. Molecular and clinical oncology, 4(1), 47-50. https://doi.org/10.3892/mco.2015.668
Kiba, Takayoshi, et al. "Examination of the clinical efficacy of eribulin and trastuzumab in HER2-positive recurrent breast cancer." Molecular and clinical oncology vol. 4,1 (2016): 47-50. doi: https://doi.org/10.3892/mco.2015.668
Kiba T, Morii N, Takahashi H, Ozaki S, Atsumi M, Masumoto F, Shitakubo Y, Yamashiro H. Examination of the clinical efficacy of eribulin and trastuzumab in HER2-positive recurrent breast cancer. Mol Clin Oncol. 2016 Jan;4(1):47-50. doi: 10.3892/mco.2015.668. Epub 2015 Nov 05. PMID: 26870356; PMCID: PMC4727054.
Copy Download .nbib Format: NLM
Microbial metabolites and derivatives targeted at inflammation and bone diseases therapy: chemistry, biological activity and pharmacology.

The Journal of antibiotics

Adachi H, Nakae K, Sakamoto S, Nosaka C, Atsumi S, Shibuya M, Higashi N, Nakajima M, Irimura T, Nishimura Y.
PMID: 29089599
J Antibiot (Tokyo). 2017 Nov 01; doi: 10.1038/ja.2017.138. Epub 2017 Nov 01.

Microbial metabolites have attracted increasing interest as a source of therapeutics and as probes for biological mechanisms. New microbial metabolites and derivatives targeted at inflammation and bone disease therapy have been identified by focusing on prostaglandin release, osteoblast differentiation...

Cite
Adachi H, Nakae K, Sakamoto S, et al. Microbial metabolites and derivatives targeted at inflammation and bone diseases therapy: chemistry, biological activity and pharmacology. J Antibiot (Tokyo). 2017;doi: 10.1038/ja.2017.138.
Adachi, H., Nakae, K., Sakamoto, S., Nosaka, C., Atsumi, S., Shibuya, M., Higashi, N., Nakajima, M., Irimura, T., & Nishimura, Y. (2017). Microbial metabolites and derivatives targeted at inflammation and bone diseases therapy: chemistry, biological activity and pharmacology. The Journal of antibiotics, . https://doi.org/10.1038/ja.2017.138
Adachi, Hayamitsu, et al. "Microbial metabolites and derivatives targeted at inflammation and bone diseases therapy: chemistry, biological activity and pharmacology." The Journal of antibiotics vol. (2017). doi: https://doi.org/10.1038/ja.2017.138
Adachi H, Nakae K, Sakamoto S, Nosaka C, Atsumi S, Shibuya M, Higashi N, Nakajima M, Irimura T, Nishimura Y. Microbial metabolites and derivatives targeted at inflammation and bone diseases therapy: chemistry, biological activity and pharmacology. J Antibiot (Tokyo). 2017 Nov 01; doi: 10.1038/ja.2017.138. Epub 2017 Nov 01. PMID: 29089599.
Copy Download .nbib Format: NLM
Pathological complete response rate in hormone receptor-negative breast cancer treated with neoadjuvant FEC, followed by weekly paclitaxel administration: A retrospective study and review of the literature.

Oncology letters

Kiba T, Morii N, Takahashi H, Ozaki S, Atsumi M, Masumoto F, Yamashiro H.
PMID: 27123064
Oncol Lett. 2016 May;11(5):3064-3070. doi: 10.3892/ol.2016.4334. Epub 2016 Mar 16.

While tumor size, the presence of inflammatory carcinoma and lymph node involvement are the main prognostic factors of women with locally advanced breast cancer, the prognostic value of the estrogen receptor, progesterone receptor and human epidermal growth factor receptor...

Cite
Kiba T, Morii N, Takahashi H, et al. Pathological complete response rate in hormone receptor-negative breast cancer treated with neoadjuvant FEC, followed by weekly paclitaxel administration: A retrospective study and review of the literature. Oncol Lett. 2016;11(5):3064-3070doi: 10.3892/ol.2016.4334.
Kiba, T., Morii, N., Takahashi, H., Ozaki, S., Atsumi, M., Masumoto, F., & Yamashiro, H. (2016). Pathological complete response rate in hormone receptor-negative breast cancer treated with neoadjuvant FEC, followed by weekly paclitaxel administration: A retrospective study and review of the literature. Oncology letters, 11(5), 3064-3070. https://doi.org/10.3892/ol.2016.4334
Kiba, Takayoshi, et al. "Pathological complete response rate in hormone receptor-negative breast cancer treated with neoadjuvant FEC, followed by weekly paclitaxel administration: A retrospective study and review of the literature." Oncology letters vol. 11,5 (2016): 3064-3070. doi: https://doi.org/10.3892/ol.2016.4334
Kiba T, Morii N, Takahashi H, Ozaki S, Atsumi M, Masumoto F, Yamashiro H. Pathological complete response rate in hormone receptor-negative breast cancer treated with neoadjuvant FEC, followed by weekly paclitaxel administration: A retrospective study and review of the literature. Oncol Lett. 2016 May;11(5):3064-3070. doi: 10.3892/ol.2016.4334. Epub 2016 Mar 16. PMID: 27123064; PMCID: PMC4841046.
Copy Download .nbib Format: NLM
Concomitant fat embolism syndrome and pulmonary embolism in a patient with a femoral shaft fracture.

Acute medicine & surgery

Ebina M, Inoue A, Atsumi T, Ariyoshi K.
PMID: 29123766
Acute Med Surg. 2015 Jul 03;3(2):135-138. doi: 10.1002/ams2.127. eCollection 2016 Apr.

CASE: A 22-year-old man was injured in a traffic accident and developed respiratory distress on his first day of admission. On postadmission day 3, he developed serious respiratory distress with a suddenly altered mental status. Chest computed tomography revealed...

Cite
Ebina M, Inoue A, Atsumi T, et al. Concomitant fat embolism syndrome and pulmonary embolism in a patient with a femoral shaft fracture. Acute Med Surg. 2015;3(2):135-138doi: 10.1002/ams2.127.
Ebina, M., Inoue, A., Atsumi, T., & Ariyoshi, K. (2016). Concomitant fat embolism syndrome and pulmonary embolism in a patient with a femoral shaft fracture. Acute medicine & surgery, 3(2), 135-138. https://doi.org/10.1002/ams2.127
Ebina, Masatomo, et al. "Concomitant fat embolism syndrome and pulmonary embolism in a patient with a femoral shaft fracture." Acute medicine & surgery vol. 3,2 (2016): 135-138. doi: https://doi.org/10.1002/ams2.127
Ebina M, Inoue A, Atsumi T, Ariyoshi K. Concomitant fat embolism syndrome and pulmonary embolism in a patient with a femoral shaft fracture. Acute Med Surg. 2015 Jul 03;3(2):135-138. doi: 10.1002/ams2.127. eCollection 2016 Apr. PMID: 29123766; PMCID: PMC5667392.
Copy Download .nbib Format: NLM
Strain differentiation of 13 indigenous Mycobacterium bovis isolates from infected cattle by restriction fragment length polymorphism analysis.

International journal of mycobacteriology

Rezaee S, Mojgani N, Mosavari N, Hashmi M.
PMID: 28043569
Int J Mycobacteriol. 2016 Dec;5:S224-S225. doi: 10.1016/j.ijmyco.2016.10.020. Epub 2016 Oct 27.

Mycobacterium bovis is mainly detected in cattle throughout the world. This bacterium is considered the main causative agent of tuberculosis in man and animals. M. bovis is also reported to be endemic in badgers and in farmed and feral...

Cite
Rezaee S, Mojgani N, Mosavari N, et al. Strain differentiation of 13 indigenous Mycobacterium bovis isolates from infected cattle by restriction fragment length polymorphism analysis. Int J Mycobacteriol. 2016;5:S224-S225doi: 10.1016/j.ijmyco.2016.10.020.
Rezaee, S., Mojgani, N., Mosavari, N., & Hashmi, M. (2016). Strain differentiation of 13 indigenous Mycobacterium bovis isolates from infected cattle by restriction fragment length polymorphism analysis. International journal of mycobacteriology, 5S224-S225. https://doi.org/10.1016/j.ijmyco.2016.10.020
Rezaee, Shima, et al. "Strain differentiation of 13 indigenous Mycobacterium bovis isolates from infected cattle by restriction fragment length polymorphism analysis." International journal of mycobacteriology vol. 5 (2016): S224-S225. doi: https://doi.org/10.1016/j.ijmyco.2016.10.020
Rezaee S, Mojgani N, Mosavari N, Hashmi M. Strain differentiation of 13 indigenous Mycobacterium bovis isolates from infected cattle by restriction fragment length polymorphism analysis. Int J Mycobacteriol. 2016 Dec;5:S224-S225. doi: 10.1016/j.ijmyco.2016.10.020. Epub 2016 Oct 27. PMID: 28043569.
Copy Download .nbib Format: NLM
A novel mutation of .

Human genome variation

Oshima T, Hara H, Takeda N, Hasumi E, Kuroda Y, Taniguchi G, Inuzuka R, Nawata K, Morita H, Komuro I.
PMID: 28584646
Hum Genome Var. 2017 Jun 01;4:17022. doi: 10.1038/hgv.2017.22. eCollection 2017.

Malan syndrome has recently been characterized to present Sotos-like phenotypes, such as intellectual disability and macrocephaly, with mutations in the

Cite
Oshima T, Hara H, Takeda N, et al. A novel mutation of . Hum Genome Var. 2017;4:17022doi: 10.1038/hgv.2017.22.
Oshima, T., Hara, H., Takeda, N., Hasumi, E., Kuroda, Y., Taniguchi, G., Inuzuka, R., Nawata, K., Morita, H., & Komuro, I. (2017). A novel mutation of . Human genome variation, 417022. https://doi.org/10.1038/hgv.2017.22
Oshima, Tsukasa, et al. "A novel mutation of ." Human genome variation vol. 4 (2017): 17022. doi: https://doi.org/10.1038/hgv.2017.22
Oshima T, Hara H, Takeda N, Hasumi E, Kuroda Y, Taniguchi G, Inuzuka R, Nawata K, Morita H, Komuro I. A novel mutation of . Hum Genome Var. 2017 Jun 01;4:17022. doi: 10.1038/hgv.2017.22. eCollection 2017. PMID: 28584646; PMCID: PMC5451486.
Copy Download .nbib Format: NLM
Two patients with osteochondral injury of the weight-bearing portion of the lateral femoral condyle associated with lateral dislocation of the patella.

Case reports in orthopedics

Nakagawa S, Arai Y, Inoue H, Atsumi S, Ichimaru S, Ikoma K, Fujiwara H, Kubo T.
PMID: 25506015
Case Rep Orthop. 2014;2014:876410. doi: 10.1155/2014/876410. Epub 2014 Nov 18.

Complications of patellar dislocation include osteochondral injury of the lateral femoral condyle and patella. Most cases of osteochondral injury occur in the anterior region, which is the non-weight-bearing portion of the lateral femoral condyle. We describe two patients with...

Cite
Nakagawa S, Arai Y, Inoue H, et al. Two patients with osteochondral injury of the weight-bearing portion of the lateral femoral condyle associated with lateral dislocation of the patella. Case Rep Orthop. 2014;2014:876410doi: 10.1155/2014/876410.
Nakagawa, S., Arai, Y., Inoue, H., Atsumi, S., Ichimaru, S., Ikoma, K., Fujiwara, H., & Kubo, T. (2014). Two patients with osteochondral injury of the weight-bearing portion of the lateral femoral condyle associated with lateral dislocation of the patella. Case reports in orthopedics, 2014876410. https://doi.org/10.1155/2014/876410
Nakagawa, Shuji, et al. "Two patients with osteochondral injury of the weight-bearing portion of the lateral femoral condyle associated with lateral dislocation of the patella." Case reports in orthopedics vol. 2014 (2014): 876410. doi: https://doi.org/10.1155/2014/876410
Nakagawa S, Arai Y, Inoue H, Atsumi S, Ichimaru S, Ikoma K, Fujiwara H, Kubo T. Two patients with osteochondral injury of the weight-bearing portion of the lateral femoral condyle associated with lateral dislocation of the patella. Case Rep Orthop. 2014;2014:876410. doi: 10.1155/2014/876410. Epub 2014 Nov 18. PMID: 25506015; PMCID: PMC4251879.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 576 entries